Uncovering the Link Between Endogenous Brain Steroids & Inflammasomes to Uncover Novel Mechanisms of Inhibiting the Inflammasome Pathway
Time: 3:30 pm
day: Day 1
Details:
- GRX-917, through inducing endogenous neurosteroid production and inhibiting NLRP3 inflammation, presents a novel approach with potential benefits across neuropsychiatric, neurological, and autoimmune disorders
- Exploring GRX-917’s improved pharmacokinetic profile derived from deuterium stabilization while maintaining efficacy and safety akin to its predecessor, Etifoxine
